Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Mutagen sensitivity of patients with cancer at different sites of the head and neck

By Székely Gábor   Remenár Éva  

Mutagenesis, Vol. 20, Iss. 5, 2005-09 ,pp. : 381-385

Oxford University Press

Access to resources Recommend Favorite

Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives

By Burgaz Sema   Coskun Erdem   Demircigil Gonca Cakmak   Kocabas Neslihan Aygun   Cetindag Faik   Sunter Osman   Edinsel Hayriye  

Mutagenesis, Vol. 26, Iss. 2, 2011-03 ,pp. : 351-356

Oxford University Press

Access to resources Recommend Favorite

Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients

By Khlifi Rim   Chakroun Amine   Hamza-Chaffai Amel   Rebai Ahmed  

Molecular Biology Reports, Vol. 41, Iss. 4, 2014-04 ,pp. : 2591-2600

Springer Publishing Company

Access to resources Recommend Favorite

Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite